UBS Group AG
Position in CRL — Charles River Laboratories International, Inc.
CIK 1610520
ZURICH, V8
Position in CRL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$146,675,750
+$20,498,038 QoQ
Shares Held
646,747
-11.6% QoQ
Ownership
1.35%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#25
of 570 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in CRL Over Time
Shares Held
Position Value (USD)
Derivatives in CRL
reported options exposure · as of Jun 30, 2026CallValue
$3,855,430
CallShares
17,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026UBS Group AG holds $4,492,966,338 across 42 Diagnostics & Research names. CRL ranks #12 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
2,521,208 | $1,264,032,836 | |
| 2 | DHR |
Danaher Corp /De/
|
3,243,524 | $617,826,447 | |
| 3 | WAT |
Waters Corp /De/
|
694,851 | $260,596,916 | |
| 4 | A |
Agilent Technologies, Inc.
|
1,574,629 | $209,157,967 | |
| 5 | RVTY |
Revvity, Inc.
|
1,864,464 | $207,440,262 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
364,663 | $191,973,186 | |
| 7 | DGX |
Quest Diagnostics Inc
|
888,906 | $188,403,625 | |
| 8 | MTD |
Mettler Toledo International Inc/
|
128,025 | $163,553,216 |
All Filings in CRL
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,855,430 | 17,000 | Call | Defined | 2026-08-13 | |
| 2026-06-30 | $146,675,750 | 646,747 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $126,177,712 | 731,465 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $77,563,207 | 388,827 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $92,742,601 | 592,756 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $111,562,363 | 735,269 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $360,011,477 | 2,391,785 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $61,963,203 | 335,662 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $32,286,529 | 163,916 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $30,251,986 | 146,442 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $32,824,777 | 121,147 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $22,428,448 | 94,875 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $19,992,310 | 102,012 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $23,308,733 | 110,862 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $21,899,687 | 108,511 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $18,401,654 | 84,450 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $10,585,281 | 53,787 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $6,388,286 | 29,856 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $14,915,521 | 52,525 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $30,225,290 | 80,220 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $36,957,897 | 89,558 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $27,700,348 | 74,882 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $16,432,200 | 56,696 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $16,273,381 | 65,130 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $11,154,020 | 49,256 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $3,705,982 | 21,256 | Shares | Defined | 2020-07-31 | |
| 2020-03-31 | $2,763,114 | 21,893 | Shares | Defined | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||